We know what’s coming and we are prepared.
Another significant concern surrounding the use of blood from individuals injected with the mRNA COVID-19 jabs is immune dysfunction. Undoubtedly, gene-damaging jabs have the potential to lead to immune-related complications, including immune imprinting, antibody-dependent enhancement, and alterations in immunoglobulin class switching. These phenomena can influence the immune system’s response to subsequent infections, potentially increasing susceptibility to specific pathogens or autoimmune reactions. Significantly, with the spike protein still detectable in the bodies of injected people several months after getting the jab, the risk of immune imprinting is most likely higher than in conventional vaccines
🌆 Market News Digest
[July 3, 2026 EST]
🔥 Top Stories
• Middle East risk flares — IDF hits Hezbollah sites in south Lebanon; Houthis threaten Saudi assets; France deploys naval/mine-countermeasure assets near Hormuz.
• U.S. oil market scrutiny — DOJ/FTC say they’re monitoring crude for price-fixing/collusion as Brent settles at $72.12/bbl.
• Trump pardons saga — Trump signs pardons for six and faces fresh scrutiny after NBC reported undisclosed stock purchases before tariff pause.
⛽ Oil & Energy
• Gulf crude exports topped 10M bpd in June but remain ~40% below pre-conflict levels; Fitch flags ongoing Iran/Mideast risk to corporates and oil forecasts.
• CMA CGM warns Hormuz transit charges would be “devastating”; Airbus says defense cooperation remains pressured.
📊 Markets & Macro
• Germany’s 2027 draft budget lifts borrowing to €203.7B and spending to €555.4B; euro equities firm with DAX +0.85%.
• ECB/BoE message: inflation still the focus, but Bailey says UK ...
